Guardian Pharmacy Services, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
Mary Sue Patchett, a Director at Guardian Pharmacy Services, Inc., reported the acquisition of 4,028 shares of Class A Common Stock on May 5, 2026.
NYSE
Pharmacy Investors, LLC, a member of a 10% owner group, converted 1,413,939 shares of Guardian Pharmacy Services, Inc. Class B common stock to Class A common stock.
NYSE
William E. Bindley, a Director and 10% Owner of Guardian Pharmacy Services, Inc., converted over 6 million Class B common shares into Class A common shares as part of a pre-scheduled event.
NYSE
Kendall Forbes, EVP of Guardian Pharmacy Services, converted 608,570 Class B common shares to Class A common shares as part of a scheduled plan.
NYSE
David K. Morris, CFO of Guardian Pharmacy Services, Inc., converted 641,869 shares of Class B common stock into Class A common stock as part of a pre-scheduled automatic conversion.
NYSE
Cardinal Equity Fund, L.P. converted 471,057 Class B common shares of Guardian Pharmacy Services, Inc. into Class A common shares as part of a pre-scheduled automatic conversion.
NYSE
Bindley Capital Partners I, LLC converted 6,100,175 shares of Guardian Pharmacy Services, Inc. Class B common stock into Class A common stock.
NYSE
A director and 10% owner of Guardian Pharmacy Services converted Class B common stock into Class A common stock, increasing their beneficial ownership of Class A shares.
NYSE
A director and 10% owner of Guardian Pharmacy Services, Inc. reported the automatic conversion of over 6.1 million Class B common shares into Class A common shares.
NYSE
Guardian Pharmacy Services CEO Fred Burke converted over 1.2 million Class B common shares to Class A common shares as part of a pre-scheduled automatic conversion.
NYSE
Pharmacy Investors, LLC reported the sale of 827,636 shares of Guardian Pharmacy Services, Inc. Class A Common Stock for $29.6825 per share.
NYSE
Guardian Pharmacy Services' CFO, David K. Morris, sold 187,855 shares of Class A common stock for approximately $5.58 million under a pre-arranged plan.
NYSE
Fred Burke, President and CEO of Guardian Pharmacy Services, Inc., sold 671,432 shares of Class A Common Stock for approximately $19.9 million.
NYSE
Kendall Forbes, Executive Vice President of Guardian Pharmacy Services, sold 346,672 shares of Class A Common Stock for approximately $10.3 million.
NYSE
Cardinal Equity Fund, a 10% owner, sold 275,728 shares of Guardian Pharmacy Services Class A Common Stock for approximately $8.19 million.
NYSE
A director and 10% owner of Guardian Pharmacy Services, Inc. sold over 3.6 million shares of Class A Common Stock for approximately $107 million.
NYSE
Bindley Capital Partners I, LLC, a 10% owner and director of Guardian Pharmacy Services, Inc., reported the sale of 3,570,677 shares of Class A common stock for approximately $106 million.
NYSE
John Ackerman, a Director and 10% owner of Guardian Pharmacy Services, Inc., sold over 1.1 million shares of Class A Common Stock at $29.6825 per share through an underwritten agreement.
NYSE
Guardian Pharmacy Services Director and 10% owner William E. Bindley sold over 3.5 million shares of Class A Common Stock for approximately $106 million.
NYSE
Fred Burke, CEO of Guardian Pharmacy Services, gifted 200,000 shares of Class A Common Stock to a charitable donor-advised fund.
NYSE
Kendall Forbes, Executive Vice President of Guardian Pharmacy Services, gifted 21,500 shares of Class A Common Stock to a charitable donor-advised fund.
NYSE
A director at Guardian Pharmacy Services, Steven D. Cosler, purchased 3,370 shares of Class A Common Stock for approximately $99,889.70.
NYSE
Director John Ackerman reported the automatic conversion of Class B to Class A common stock for Guardian Pharmacy Services, Inc. through indirect holdings.
NYSE
Kendall Forbes, Executive Vice President of Sales & Operations at Guardian Pharmacy Services, Inc., reported the first of three automatic conversions of 608,570 Class B common shares into Class A common shares.
NYSE
Cardinal Equity Fund, a member of a 10% owner group, reported sales of Guardian Pharmacy Services Class A common stock and an automatic conversion of Class B to Class A shares.
NYSE
Bindley Capital Partners I, LLC, a 10% owner and director, reported the automatic conversion of 6,100,176 Class B common shares into Class A common shares of Guardian Pharmacy Services, Inc.
NYSE
Thomas J. Salentine Jr., a Director and 10% owner of Guardian Pharmacy Services, Inc., reported the automatic conversion of over 6 million Class B common shares into Class A common shares.
NYSE
Guardian Pharmacy Services CFO David K. Morris converted Class B shares to Class A and disclosed future share transfers related to a divorce settlement.
NYSE
William E. Bindley, a Director and 10% owner of Guardian Pharmacy Services, Inc., reported the future automatic conversion of 6,100,176 Class B common shares into Class A common shares, scheduled for September 27, 2025.
NYSE
Pharmacy Investors, LLC, a 10% owner of Guardian Pharmacy Services, Inc., reported sales of Class A common stock and the automatic conversion of Class B shares into Class A shares.